title: Cyclosporine treatment decreases the percentage of cutaneous lymphocyte antigen (CLA)(+)CD4(+) T cells in children with severe atopic dermatitis.
authors.affiliation: Department of Pediatrics, University of Ulsan College of Medicine, 388-1 Poongnap-Dong, Songpa-Gu, Seoul 138-736, Korea.
authors.forename: S-Y
authors.initials: SY
authors.lastname: Lee
authors.forename: J-Y
authors.initials: JY
authors.lastname: Shim
authors.forename: J-H
authors.initials: JH
authors.lastname: Kim
authors.forename: B-S
authors.initials: BS
authors.lastname: Kim
authors.forename: H-J
authors.initials: HJ
authors.lastname: Seo
authors.forename: S-O
authors.initials: SO
authors.lastname: Choi
authors.forename: S-O
authors.initials: SO
authors.lastname: Jang
authors.forename: S-J
authors.initials: SJ
authors.lastname: Hong
mesh_terms: D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D002648:Child; D016572:Cyclosporine / Q000494:pharmacology* / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008562:Membrane Glycoproteins / Q000187:drug effects* / Q000276:immunology
chemical_list: D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm; C063419:CTAGE1 protein, human; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D016572:Cyclosporine